Panacos Pharmaceuticals, Inc. (PANC)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Feb 24, 2026
Panacos Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2007 | FY 2006 | FY 2005 | FY 2004 | FY 2003 | 2002 - 2001 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '08 Sep 30, 2008 | Dec '07 Dec 31, 2007 | Dec '06 Dec 31, 2006 | Dec '05 Dec 31, 2005 | Dec '04 Dec 31, 2004 | Dec '03 Dec 31, 2003 | 2002 - 2001 |
| Revenue | 0.1 | 0.18 | 0.28 | 1.05 | 1.34 | 1.08 | Upgrade
|
| Revenue Growth (YoY) | -45.90% | -36.62% | -72.93% | -21.54% | 24.03% | 16.47% | Upgrade
|
| Gross Profit | 0.1 | 0.18 | 0.28 | 1.05 | 1.34 | 1.08 | Upgrade
|
| Selling, General & Admin | 11.02 | 12.84 | 12.03 | 8.05 | 2.16 | 0.95 | Upgrade
|
| Research & Development | 23.31 | 25.09 | 24.55 | 17.4 | 8.75 | 4.46 | Upgrade
|
| Operating Expenses | 34.32 | 37.93 | 36.58 | 25.44 | 10.91 | 5.41 | Upgrade
|
| Operating Income | -34.22 | -37.75 | -36.3 | -24.39 | -9.57 | -4.33 | Upgrade
|
| Interest Expense | -3.08 | -1.13 | -0.03 | -0.07 | -0.07 | -0.17 | Upgrade
|
| Interest & Investment Income | 1.56 | 2.71 | 3.62 | 0.99 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0.01 | -0.02 | -0.01 | -0.01 | - | -0.01 | Upgrade
|
| EBT Excluding Unusual Items | -35.76 | -36.19 | -32.71 | -23.49 | -9.64 | -4.51 | Upgrade
|
| Asset Writedown | - | -1.27 | - | -13.77 | - | - | Upgrade
|
| Other Unusual Items | - | - | -5.4 | -2.4 | -2.4 | - | Upgrade
|
| Pretax Income | -35.76 | -37.46 | -38.11 | -59.08 | -12.04 | -4.51 | Upgrade
|
| Net Income | -35.76 | -37.46 | -38.11 | -59.08 | -12.04 | -4.51 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | 1.93 | 0.73 | Upgrade
|
| Net Income to Common | -35.76 | -37.46 | -38.11 | -59.08 | -13.96 | -5.24 | Upgrade
|
| Shares Outstanding (Basic) | 54 | 53 | 51 | 34 | 1 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 54 | 53 | 51 | 34 | 1 | 0 | Upgrade
|
| Shares Change (YoY) | 2.05% | 5.19% | 46.77% | 3478.27% | 138.71% | -17.62% | Upgrade
|
| EPS (Basic) | -0.67 | -0.70 | -0.75 | -1.72 | -14.51 | -13.00 | Upgrade
|
| EPS (Diluted) | -0.67 | -0.70 | -0.75 | -1.72 | -14.51 | -13.00 | Upgrade
|
| Free Cash Flow | -31.24 | -31.08 | -30.15 | -21.8 | -9.85 | -3.96 | Upgrade
|
| Free Cash Flow Per Share | -0.58 | -0.58 | -0.60 | -0.63 | -10.24 | -9.82 | Upgrade
|
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | Upgrade
|
| Operating Margin | -34568.69% | -20972.22% | -12779.93% | -2325.45% | -715.71% | -401.76% | Upgrade
|
| Profit Margin | -36116.16% | -20810.56% | -13419.01% | -5631.84% | -1044.35% | -486.18% | Upgrade
|
| Free Cash Flow Margin | -31558.59% | -17268.33% | -10615.84% | -2077.79% | -736.65% | -367.25% | Upgrade
|
| EBITDA | -33.84 | -37.21 | -35.54 | -23.77 | -9.46 | -4.25 | Upgrade
|
| D&A For EBITDA | 0.39 | 0.54 | 0.75 | 0.63 | 0.11 | 0.08 | Upgrade
|
| EBIT | -34.22 | -37.75 | -36.3 | -24.39 | -9.57 | -4.33 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.